Abstract

Henry Schein will release its quarterly results on August 04, 2026, Pre-Market. This preview synthesizes last quarter’s performance, current-quarter forecasts on revenue, margins, net profit, and adjusted EPS, segment dynamics, and prevailing analyst views within the permitted reporting window through July 28, 2026.

Market Forecast

Consensus and company-guided indicators point to current-quarter revenue of 3.37 billion US dollars with an estimated year-over-year rise of 4.73%, an estimated EBIT of 237.04 million US dollars with a 0.71% year-over-year increase, and adjusted EPS of 1.24 with a 3.75% year-over-year rise; YoY and margin signals infer stable gross profitability and modest net margin expansion, supported by last quarter’s gross margin of 31.77% and net profit margin of 3.18%. Main business highlights are expected in Global Distribution & Value-Added Services, which remains the largest revenue contributor and should benefit from steady procedure volumes and resilient consumables demand. The most promising segment is Global Specialty Products at 397.00 million US dollars last quarter, which is positioned for higher YoY gains through portfolio mix and specialty consumable uptake.

Last Quarter Review

Henry Schein reported last quarter revenue of 3.37 billion US dollars, a gross profit margin of 31.77%, GAAP net profit attributable to the parent company of 107.00 million US dollars, a net profit margin of 3.18%, and adjusted EPS of 1.32 with 14.78% year-over-year growth. A key highlight was adjusted EPS outperforming estimates, reflecting disciplined operating cost control and pricing actions that offset mixed volume trends. Main business performance included Global Distribution & Value-Added Services at 2.84 billion US dollars, Global Specialty Products at 397.00 million US dollars, and Global Technology at 173.00 million US dollars; these areas collectively sustained revenue growth, led by consumables resilience and targeted specialty offerings.

Current Quarter Outlook

Main business: Global Distribution & Value-Added Services

Global Distribution & Value-Added Services is the backbone of Henry Schein’s quarterly performance, and the latest indicators suggest continued mid-single-digit revenue growth aligned with procedure volumes and dental consumables reorder rates. Price realization achieved over the past year, together with inventory normalization downstream, supports a relatively stable gross spread even as freight and logistics pressures moderate. The segment’s breadth across consumables, small equipment, and practice supplies tends to cushion cyclical swings, allowing the company to sustain operating leverage as volumes track broadly with the market. We expect purchasing patterns to remain steady, with mix shifting modestly toward higher-value infection control and restorative categories. Any volatility is more likely to come from timing of equipment replacements rather than core consumables, preserving margin steadiness into the quarter.

Most promising business: Global Specialty Products

Global Specialty Products stands out for its potential to outgrow the corporate average, given ongoing adoption of specialty consumables and procedure-specific products in implantology, endodontics, and orthodontics. The prior-quarter base of 397.00 million US dollars provides a springboard for expansion as product refresh cycles and targeted promotions lift unit velocity. Margin characteristics in specialty products are generally above the corporate average due to premium positioning and differentiated supplier relationships, which may translate into incremental EBIT contribution even on modest revenue acceleration. We anticipate stable demand conditions, with a constructive setup into calendar back-to-school and early fall appointment schedules that historically favor specialty case starts. As long as product availability remains tight and customer service levels stay high, this segment should provide a favorable mix shift with limited pricing attrition.

Key stock price drivers this quarter

Stock performance this quarter is likely to be most influenced by the interplay between adjusted EPS delivery versus the 1.24 estimate, gross margin resilience relative to the 31.77% benchmark, and signal strength in EBIT growth versus the modest 0.71% forecasted YoY increase. Investors will be watching for commentary on consumables reorder cadence and any early read on equipment capital spending, which can sway expectations for the back half of the year. Another determinant will be the pace of margin recapture—evidence that operating efficiencies and normalized logistics costs are embedding into run-rate profitability typically supports valuation confidence. Finally, segment mix will matter: a higher share from specialty products and technology could enhance gross margin, even if headline revenue growth is in the mid-single-digit range.

Analyst Opinions

Across recent institutional commentary, the prevailing stance is constructive, with a majority leaning bullish on Henry Schein into the quarter, citing stable demand in core distribution, improving operating efficiency, and room for incremental margin improvement relative to last quarter’s baseline. Multiple sell-side notes emphasize the company’s ability to convert mid-single-digit revenue growth into EPS stability near or slightly above the 1.24 estimate, supported by segment mix and cost controls. The emphasis on consumables-led steadiness and specialty product differentiation features prominently in favorable views, with expectations that EBIT performance should be near the guided mark even with conservative assumptions on equipment cycles. Bullish analysts argue that a clean execution on gross margin and clarity on second-half mix would sustain constructive sentiment, particularly if management signals continuity in pricing discipline and service levels. They also point to the company’s track record of navigating supply chain variability and aligning inventory with practitioner demand, which reduces the risk of margin leakage. Overall, the supportive consensus is anchored in predictable volume patterns, manageable cost inputs, and a pipeline of specialty products that bolsters near-term profitability without requiring aggressive top-line acceleration.